Azenta names Martin Madaus interim CEO as John Marotta resigns

AZTA•2026-08-24

Leadership transition at Azenta

Azenta appointed director Dr. Martin Madaus as interim president and CEO in a leadership transition.

John Marotta resigned as an executive officer and director.

Madaus joined the board in 2024; he is a senior operating executive at Carlyle. He previously led Millipore, Ortho-Clinical Diagnostics, and Roche Diagnostics North America as CEO roles.

The board retained Heidrick & Struggles to run a search for a permanent CEO.

Azenta names Martin Madaus interim CEO as John Marotta resigns

Leadership transition at Azenta

Related News

Vivakor raises 2026 outlook to $3.5 billion annualized commercial activity

Allegiant Travel gains on Raymond James 'strong buy' rating upgrade

Quantum X Labs director Eliyahu Yoresh reports purchase of 4,500 common shares valued at $21,465

Coinbase-backed crypto advocacy group endorses 32 US midterm candidates

Tempus AI wins FDA clearance for ECG software flagging pulmonary hypertension signs